Our company -
The Pathelen Healthcare AG






press release: click here

COMPANY

Find out more about us


Pathelen Health Care AG is a Swiss biotech company that has developed innovative forms of therapy for the treatment and cure of various diseases in more than 7 years of research and development. Pathelen Health Care AG specializes in the fight against bacteria and multi-resistant germs.

Pathelen® Hybrid is able to easily and effectively adsorb wound exudate, biofilm and pathogenic germs due to its physical mode of action. Pathelen® Hybrid completely dispenses with cytotoxic and pharmacological agents, as these hinder the formation of granulation tissue.


Pipeline with fully developed products:

  • Pathelen® Gel for the aftercare of chronic wounds
  • PHC suspension for the treatment of cystitis with multi-resistant germs
  • Pathelen® Gel for the treatment of gingivitis


The company has built a stable and diversified product pipeline with effective active ingredients. These demonstrate the potential for new treatment options in dermatology, surgery and urology.



Pathelen Healthcare AG

Our Team –
Pathelen Healthcare AG

Consultation

Dr. Stefan Bokorny

Chemist
Board of Directors

Dr. med. Christian Köhler, MD

Practicing physician and licensed medical expert

Prof. Igor Gerashenko

Chuiko Institute of Surface Chemistry of the National Academy of Sciences of Ukraine, Kiev

Prof. Oleksii Chepliaka, MD

National Pirogov Memorial Medical University, Vinnytsya

Dr. Maxim Prystupiuk, MD

Medical Faculty University Kiev

Team

Andreas Tausch

Founder and CEO
Chairman of the Board

Dario Scheuber

Partner
braintec pharma ag
Board of Directors

Bijan Sabet

Head Legal & Marketing
Pathelen Healthcare AG

Natalija Makarenko

Business Development
Pathelen Health Care AG

Dina Kudasheva

Production Manager
Pathelen Health Care AG